Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
Jayaraman S, Hou X, Kuffel MJ, Suman VJ, Hoskin TL, Reinicke KE, Monroe DG, Kalari KR, Tang X, Zeldenrust MA, Cheng J, Bruinsma ES, Buhrow SA, McGovern RM, Safgren SL, Walden CA, Carter JM, Reid JM, Ingle JN, Ames MM, Hawse JR, Goetz MP.
Jayaraman S, et al. Among authors: reinicke ke.
Breast Cancer Res. 2020 May 19;22(1):51. doi: 10.1186/s13058-020-01286-7.
Breast Cancer Res. 2020.
PMID: 32430040
Free PMC article.